Turn Therapeutics Inc. operates as a pharmaceutical and medical device development company built around a proprietary platform technology designed to enhance drug performance.
The company's patented mixing process, commercially referred to as PermaF…
Analysis
Turn Therapeutics's 360° View rank of 65 places it above its peer average — better than 65% of its true peers.
It's lagging on growth (22) and looks cheap versus peers (100). On safety it is carrying more balance-sheet risk (37), and the market shows skeptical sentiment (11). Taken together, its Combined rank of 65 reads as above its peer average.
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
93
—
—
—
Price/Earnings
95
—
—
—
Price/Book
6
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
100
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.